1. Home
  2. CORT vs ALK Comparison

CORT vs ALK Comparison

Compare CORT & ALK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • ALK
  • Stock Information
  • Founded
  • CORT 1998
  • ALK 1932
  • Country
  • CORT United States
  • ALK United States
  • Employees
  • CORT N/A
  • ALK N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • ALK Air Freight/Delivery Services
  • Sector
  • CORT Health Care
  • ALK Consumer Discretionary
  • Exchange
  • CORT Nasdaq
  • ALK Nasdaq
  • Market Cap
  • CORT 7.5B
  • ALK 6.4B
  • IPO Year
  • CORT N/A
  • ALK N/A
  • Fundamental
  • Price
  • CORT $69.15
  • ALK $54.33
  • Analyst Decision
  • CORT Strong Buy
  • ALK Strong Buy
  • Analyst Count
  • CORT 4
  • ALK 12
  • Target Price
  • CORT $142.00
  • ALK $66.25
  • AVG Volume (30 Days)
  • CORT 856.9K
  • ALK 2.8M
  • Earning Date
  • CORT 08-05-2025
  • ALK 07-23-2025
  • Dividend Yield
  • CORT N/A
  • ALK N/A
  • EPS Growth
  • CORT 8.36
  • ALK 41.14
  • EPS
  • CORT 1.14
  • ALK 2.49
  • Revenue
  • CORT $685,446,000.00
  • ALK $13,447,000,000.00
  • Revenue This Year
  • CORT $35.85
  • ALK $22.69
  • Revenue Next Year
  • CORT $35.22
  • ALK $6.86
  • P/E Ratio
  • CORT $60.53
  • ALK $21.85
  • Revenue Growth
  • CORT 30.93
  • ALK 27.81
  • 52 Week Low
  • CORT $32.33
  • ALK $32.62
  • 52 Week High
  • CORT $117.33
  • ALK $78.08
  • Technical
  • Relative Strength Index (RSI)
  • CORT 45.05
  • ALK 59.22
  • Support Level
  • CORT $67.44
  • ALK $50.64
  • Resistance Level
  • CORT $73.78
  • ALK $53.94
  • Average True Range (ATR)
  • CORT 2.08
  • ALK 2.01
  • MACD
  • CORT -0.31
  • ALK 0.09
  • Stochastic Oscillator
  • CORT 26.97
  • ALK 86.22

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About ALK Alaska Air Group Inc.

Alaska Air Group Inc operates two airlines, Alaska and Horizon in three operating segments. The Alaska Airlines segment includes scheduled air transportation on Alaska's Boeing and Airbus jet aircraft for passengers and cargo throughout the U.S., and in parts of Mexico, and Costa Rica. The Regional segment includes Horizon's and other third-party carriers' scheduled air transportation for passengers across a shorter distance network within the U.S. and Canada under capacity purchase agreements (CPA). The Hawaiian Airlines segment includes scheduled air transportation on Hawaiian's Boeing and Airbus aircraft for passengers and cargo. It earns revenues from Passenger tickets, including ticket breakage and net of taxes and fees, Passenger ancillary and Mileage Plan passenger revenue.

Share on Social Networks: